NCT01656460View on ClinicalTrials.gov

Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

May 16, 2017

Conditions
Lung Cancer
Interventions
RADIATION

Stereotactic radiation Arm 1

"Dose Levels Dose per Fraction Total Dose~1 8 Gy 16 Gy"

RADIATION

Stereotactic radiation Arm 2

Dose Levels Dose per Fraction Total Dose 2 10 Gy 20 Gy

RADIATION

Stereotactic radiation Arm 3

Dose Levels Dose per Fraction Total Dose 3 12 Gy 24 Gy

RADIATION

Stereotactic radiation Arm 4

Dose Levels Dose per Fraction Total Dose 4 14 Gy 28 Gy

Trial Locations (2)

02860

memorial Hospital of Rhode island, Pawtucket

02903

Rhode Island Hospital, Providence

All Listed Sponsors
collaborator

Memorial Hospital of Rhode Island

OTHER

lead

Dr Thomas DiPetrillo

OTHER

NCT01656460 - Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer | Biotech Hunter | Biotech Hunter